Indeed, it was reported that several anti-diabetic drugs such as incretin-related drugs and sodium-glucose cotransporter 2 inhibitors showed favorable effects on β-cells at an early stage of diabetes but that such phenomena were not observed at an advanced stage24–26. Here, SLC5A2 is linked to diabetes mellitus.